Triple Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted Agents

Patients with metastatic triple negative breast cancer (TNBC) have poor treatment outcomes. We reviewed the electronic records of consecutive patients with metastatic TNBC treated in phase I clinic at MD Anderson between August 2005 and May 2012. One hundred and six patients received at least 1 phas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Autores principales: Ganesan, Prasanth, Moulder, Stacy, Lee, J. Jack, Janku, Filip, Valero, Vicente, Zinner, Ralph G., Naing, Aung, Fu, Siqing, Tsimberidou, Apostolia M., Hong, David, Stephen, Bettzy, Stephens, Philip, Yelensky, Roman, Meric-Bernstam, Funda, Kurzrock, Razelle, Wheler, Jennifer J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258414/
https://ncbi.nlm.nih.gov/pubmed/25253784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-14-0358
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares